Follow The Filings

ARWR position history

The shares of Arrowhead Pharmaceuticals In (ARWR) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 796,578 shares, $50M, 0.25% of portfolio
  2. 2021 Q4: 320,617 shares, $21M, 0.11% of portfolio, Reduce −59.8%
  3. 2022 Q1: 142,700 shares, $6.6M, 0.03% of portfolio, Reduce −55.5%
  4. 2022 Q2: not held, Exit
  5. 2022 Q3: not held
  6. 2022 Q4: not held
  7. 2023 Q1: not held
  8. 2023 Q2: 5,800 shares, $207K, <0.01% of portfolio, New
  9. 2023 Q3: not held, Exit
  10. 2023 Q4: not held
  11. 2024 Q1: not held
  12. 2024 Q2: not held
  13. 2024 Q3: not held
  14. 2024 Q4: 628,800 shares, $12M, 0.06% of portfolio, New
  15. 2025 Q1: 15,800 shares, $201K, <0.01% of portfolio, Reduce −97.5%
  16. 2025 Q2: 15,800 shares, $250K, <0.01% of portfolio
  17. 2025 Q3: 31,600 shares, $1.1M, <0.01% of portfolio, Add +100.0%
  18. 2025 Q4: 15,800 shares, $1M, <0.01% of portfolio, Reduce −50.0%
  19. 2026 Q1: 15,800 shares, $991K, <0.01% of portfolio
  20. 2026 Q2: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders